Aug. 30, 2023
The Advanced Research Projects Agency for Health (ARPA-H) recently announced its first proposal from its Open Broad Agency Announcement (BAA). Curing the Uncurable via RNA-Encoded Immunogene Tuning (CUREIT) will fund up to $24 million to Emory University to fight cancer and other diseases with the goal of developing generalizable mRNA platforms to treat diverse diseases.

The White House released a statement applauding the project and noting the tie to the Cancer Moonshot initiative. The Cancer Moonshot initiative was reignited last year by the Biden Administration to end cancer as we know it.

The American College of Radiology® (ACR®) was an early supporter of the Cancer Moonshot in early spring 2022, meeting with the U.S. Department of Health and Human Services (HHS) to offer the College as a resource for the nonpartisan effort. The ongoing dialogue with HHS resulted in the secretary of the agency visiting an ACR-accredited mammography site in Nevada to stress the importance of regular breast cancer screening.

CUREIT is the first award from the Open BAA, which seeks transformative ideas for health research breakthroughs or technological advancements. The application period is open until March 2024, and future projects will be funded on a rolling basis.

For more information, contact Katie Grady, ACR Government Affairs Director.

Related ACR News

  • Supreme Court Upholds Preventive Services Coverage

    ACR commends the Supreme Court’s ruling affirming the constitutionality of the structure and appointment process of the U.S. Preventive Services Task Force.

    Read more
  • ACR Drives Urgency For Medicare Pay Fix in Senate Bill

    ACR highlighted the urgent need for a permanent Medicare physician pay fix in a June 23 letter to U.S. Senate leaders.

    Read more
  • ACR Urges Senate to Reconsider Student Loan Program Changes

    ACR and other medical groups cautioned that the student loan provisions would make medical and dental education less accessible to many qualified individuals.

    Read more